Pathway Name	Avg Num Perturbations	Total Perturbations	Num Entities	Min Mean Truth	Max Mean Truth	Min Mean Within	Max Mean Within	Min Mean Any	Max Mean Within
Ephrin A  reverse signaling	9.0	66.0	7.0	-0.138	-0.0	1000.0	-1000.0	-0.007	-1000.0
Nephrin/Neph1 signaling in the kidney podocyte	7.0	248.0	34.0	-0.164	0.029	1000.0	-1000.0	-0.033	-1000.0
Ephrin B reverse signaling	5.0	246.0	48.0	-0.214	0.029	1000.0	-1000.0	-0.025	-1000.0
E-cadherin signaling events	5.0	25.0	5.0	-0.093	0.025	1000.0	-1000.0	0.003	-1000.0
Syndecan-1-mediated signaling events	4.0	143.0	34.0	-0.176	0.028	1000.0	-1000.0	-0.046	-1000.0
Signaling events mediated by the Hedgehog family	4.0	250.0	52.0	-0.165	0.091	1000.0	-1000.0	-0.032	-1000.0
IL4-mediated signaling events	4.0	402.0	91.0	-0.491	0.441	1000.0	-1000.0	-0.084	-1000.0
Glucocorticoid receptor regulatory network	4.0	511.0	114.0	-0.527	0.193	1000.0	-1000.0	-0.053	-1000.0
Reelin signaling pathway	4.0	245.0	56.0	-0.126	0.044	1000.0	-1000.0	-0.043	-1000.0
Endothelins	4.0	432.0	96.0	-0.213	0.068	1000.0	-1000.0	-0.046	-1000.0
Stabilization and expansion of the E-cadherin adherens junction	4.0	346.0	74.0	-0.104	0.039	1000.0	-1000.0	-0.066	-1000.0
TCGA08_retinoblastoma	4.0	38.0	8.0	-0.031	0.085	1000.0	-1000.0	-0.001	-1000.0
IL23-mediated signaling events	4.0	263.0	60.0	-0.428	0.028	1000.0	-1000.0	-0.077	-1000.0
Thromboxane A2 receptor signaling	3.0	364.0	105.0	-0.174	0.081	1000.0	-1000.0	-0.044	-1000.0
p75(NTR)-mediated signaling	3.0	390.0	125.0	-0.15	0.074	1000.0	-1000.0	-0.069	-1000.0
BMP receptor signaling	3.0	261.0	81.0	-0.135	0.055	1000.0	-1000.0	-0.049	-1000.0
Signaling events regulated by Ret tyrosine kinase	3.0	282.0	82.0	-0.105	0.029	1000.0	-1000.0	-0.061	-1000.0
EPHB forward signaling	3.0	281.0	85.0	-0.096	0.074	1000.0	-1000.0	-0.06	-1000.0
Glypican 2 network	3.0	13.0	4.0	-0.009	-0.003	1000.0	-1000.0	0.002	-1000.0
Calcium signaling in the CD4+ TCR pathway	3.0	93.0	31.0	-0.206	0.028	1000.0	-1000.0	-0.038	-1000.0
IL6-mediated signaling events	3.0	238.0	75.0	-0.332	0.055	1000.0	-1000.0	-0.043	-1000.0
Calcineurin-regulated NFAT-dependent transcription in lymphocytes	3.0	270.0	68.0	-0.263	0.069	1000.0	-1000.0	-0.078	-1000.0
E-cadherin signaling in the nascent adherens junction	3.0	236.0	76.0	-0.116	0.042	1000.0	-1000.0	-0.059	-1000.0
Angiopoietin receptor Tie2-mediated signaling	3.0	281.0	88.0	-0.161	0.034	1000.0	-1000.0	-0.067	-1000.0
ErbB2/ErbB3 signaling events	2.0	187.0	65.0	-0.106	0.038	1000.0	-1000.0	-0.065	-1000.0
Caspase cascade in apoptosis	2.0	151.0	74.0	-0.077	0.074	1000.0	-1000.0	-0.031	-1000.0
IL12-mediated signaling events	2.0	206.0	87.0	-0.229	0.029	1000.0	-1000.0	-0.081	-1000.0
Lissencephaly gene (LIS1) in neuronal migration and development	2.0	137.0	54.0	-0.118	0.031	1000.0	-1000.0	-0.057	-1000.0
HIF-1-alpha transcription factor network	2.0	198.0	76.0	-0.187	0.042	1000.0	-1000.0	-0.06	-1000.0
Arf6 signaling events	2.0	162.0	62.0	-0.161	0.038	1000.0	-1000.0	-0.029	-1000.0
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met)	2.0	254.0	85.0	-0.154	0.081	1000.0	-1000.0	-0.036	-1000.0
FOXA2 and FOXA3 transcription factor networks	2.0	129.0	46.0	-0.229	0.033	1000.0	-1000.0	-0.085	-1000.0
Glypican 1 network	2.0	102.0	48.0	-0.126	0.042	1000.0	-1000.0	-0.025	-1000.0
Fc-epsilon receptor I signaling in mast cells	2.0	259.0	97.0	-0.075	0.044	1000.0	-1000.0	-0.055	-1000.0
IFN-gamma pathway	2.0	144.0	68.0	-0.114	0.034	1000.0	-1000.0	-0.055	-1000.0
amb2 Integrin signaling	2.0	227.0	82.0	-0.178	0.035	1000.0	-1000.0	-0.034	-1000.0
FAS signaling pathway (CD95)	2.0	134.0	47.0	-0.222	0.048	1000.0	-1000.0	-0.039	-1000.0
Signaling mediated by p38-alpha and p38-beta	2.0	128.0	44.0	-0.074	0.028	1000.0	-1000.0	-0.028	-1000.0
Integrins in angiogenesis	2.0	234.0	84.0	-0.136	0.05	1000.0	-1000.0	-0.048	-1000.0
TCR signaling in naïve CD8+ T cells	2.0	220.0	93.0	-0.071	0.038	1000.0	-1000.0	-0.051	-1000.0
Canonical Wnt signaling pathway	2.0	103.0	51.0	-0.187	0.076	1000.0	-1000.0	-0.053	-1000.0
Effects of Botulinum toxin	2.0	63.0	26.0	-0.049	0.029	1000.0	-1000.0	-0.01	-1000.0
Nongenotropic Androgen signaling	2.0	135.0	52.0	-0.117	0.067	1000.0	-1000.0	-0.035	-1000.0
Signaling events mediated by VEGFR1 and VEGFR2	2.0	288.0	125.0	-0.06	0.04	1000.0	-1000.0	-0.049	-1000.0
Wnt signaling	2.0	19.0	7.0	-0.048	0.003	1000.0	-1000.0	-0.029	-1000.0
EGFR-dependent Endothelin signaling events	2.0	54.0	21.0	-0.05	0.038	1000.0	-1000.0	-0.043	-1000.0
Syndecan-4-mediated signaling events	2.0	198.0	67.0	-0.103	0.073	1000.0	-1000.0	-0.039	-1000.0
Neurotrophic factor-mediated Trk receptor signaling	2.0	264.0	120.0	-0.122	0.067	1000.0	-1000.0	-0.048	-1000.0
Visual signal transduction: Rods	2.0	121.0	52.0	-0.084	0.03	1000.0	-1000.0	-0.032	-1000.0
E-cadherin signaling in keratinocytes	2.0	109.0	43.0	-0.111	0.03	1000.0	-1000.0	-0.033	-1000.0
LPA4-mediated signaling events	1.0	23.0	12.0	-0.039	0.01	1000.0	-1000.0	-0.018	-1000.0
Regulation of nuclear SMAD2/3 signaling	1.0	182.0	136.0	-0.231	0.17	1000.0	-1000.0	-0.033	-1000.0
Coregulation of Androgen receptor activity	1.0	106.0	76.0	-0.071	0.045	1000.0	-1000.0	-0.026	-1000.0
ErbB4 signaling events	1.0	118.0	69.0	-0.102	0.062	1000.0	-1000.0	-0.051	-1000.0
BARD1 signaling events	1.0	74.0	57.0	-0.032	0.05	1000.0	-1000.0	-0.044	-1000.0
PLK2 and PLK4 events	1.0	3.0	3.0	-0.002	0.019	1000.0	-1000.0	-0.015	-1000.0
Visual signal transduction: Cones	1.0	48.0	38.0	-0.037	0.027	1000.0	-1000.0	-0.015	-1000.0
Osteopontin-mediated events	1.0	61.0	38.0	-0.064	0.031	1000.0	-1000.0	-0.04	-1000.0
JNK signaling in the CD4+ TCR pathway	1.0	17.0	17.0	-0.043	0.044	1000.0	-1000.0	-0.041	-1000.0
Noncanonical Wnt signaling pathway	1.0	51.0	26.0	-0.072	0.028	1000.0	-1000.0	-0.053	-1000.0
Syndecan-2-mediated signaling events	1.0	91.0	69.0	-0.085	0.043	1000.0	-1000.0	-0.026	-1000.0
Cellular roles of Anthrax toxin	1.0	54.0	39.0	-0.042	0.026	1000.0	-1000.0	-0.023	-1000.0
Signaling events mediated by PTP1B	1.0	122.0	76.0	-0.129	0.045	1000.0	-1000.0	-0.031	-1000.0
Presenilin action in Notch and Wnt signaling	1.0	101.0	61.0	-0.188	0.069	1000.0	-1000.0	-0.043	-1000.0
Nectin adhesion pathway	1.0	112.0	63.0	-0.14	0.039	1000.0	-1000.0	-0.049	-1000.0
Ceramide signaling pathway	1.0	95.0	76.0	-0.055	0.05	1000.0	-1000.0	-0.035	-1000.0
IL1-mediated signaling events	1.0	67.0	62.0	-0.033	0.063	1000.0	-1000.0	-0.043	-1000.0
S1P5 pathway	1.0	21.0	17.0	-0.02	0.026	1000.0	-1000.0	-0.015	-1000.0
ceramide signaling pathway	1.0	59.0	49.0	-0.0	0.041	1000.0	-1000.0	-0.038	-1000.0
RXR and RAR heterodimerization with other nuclear receptor	1.0	60.0	52.0	-0.088	0.068	1000.0	-1000.0	-0.035	-1000.0
HIF-2-alpha transcription factor network	1.0	57.0	43.0	-0.1	0.045	1000.0	-1000.0	-0.06	-1000.0
S1P1 pathway	1.0	66.0	36.0	-0.054	0.027	1000.0	-1000.0	-0.036	-1000.0
TCGA08_p53	1.0	11.0	7.0	-0.026	0.026	1000.0	-1000.0	-0.008	-1000.0
FoxO family signaling	1.0	65.0	64.0	-0.094	0.051	1000.0	-1000.0	-0.048	-1000.0
Signaling mediated by p38-gamma and p38-delta	1.0	27.0	15.0	-0.025	0.028	1000.0	-1000.0	-0.028	-1000.0
Retinoic acid receptors-mediated signaling	1.0	97.0	58.0	-0.064	0.05	1000.0	-1000.0	-0.043	-1000.0
IL2 signaling events mediated by PI3K	1.0	64.0	58.0	-0.056	0.048	1000.0	-1000.0	-0.037	-1000.0
HIV-1 Nef: Negative effector of Fas and TNF-alpha	1.0	45.0	45.0	-0.008	0.047	1000.0	-1000.0	-0.049	-1000.0
Regulation of p38-alpha and p38-beta	1.0	74.0	54.0	-0.098	0.056	1000.0	-1000.0	-0.044	-1000.0
IL27-mediated signaling events	1.0	67.0	51.0	-0.119	0.07	1000.0	-1000.0	-0.046	-1000.0
TCGA08_rtk_signaling	1.0	30.0	26.0	-0.064	0.062	1000.0	-1000.0	-0.009	-1000.0
LPA receptor mediated events	1.0	124.0	102.0	-0.065	0.055	1000.0	-1000.0	-0.055	-1000.0
IL2 signaling events mediated by STAT5	1.0	24.0	22.0	-0.04	0.029	1000.0	-1000.0	-0.042	-1000.0
Regulation of Telomerase	1.0	129.0	102.0	-0.214	0.066	1000.0	-1000.0	-0.055	-1000.0
BCR signaling pathway	1.0	184.0	99.0	-0.119	0.038	1000.0	-1000.0	-0.051	-1000.0
IGF1 pathway	1.0	75.0	57.0	-0.024	0.047	1000.0	-1000.0	-0.038	-1000.0
Plasma membrane estrogen receptor signaling	1.0	142.0	86.0	-0.082	0.051	1000.0	-1000.0	-0.057	-1000.0
VEGFR1 specific signals	1.0	59.0	56.0	-0.045	0.029	1000.0	-1000.0	-0.053	-1000.0
S1P3 pathway	1.0	77.0	42.0	-0.173	0.036	1000.0	-1000.0	-0.031	-1000.0
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha	1.0	42.0	33.0	-0.041	0.056	1000.0	-1000.0	-0.034	-1000.0
PDGFR-beta signaling pathway	1.0	108.0	97.0	-0.064	0.054	1000.0	-1000.0	-0.05	-1000.0
Class IB PI3K non-lipid kinase events	1.0	3.0	3.0	-0.021	0.021	1000.0	-1000.0	-0.006	-1000.0
FOXM1 transcription factor network	1.0	101.0	51.0	-0.063	0.083	1000.0	-1000.0	-0.088	-1000.0
S1P4 pathway	1.0	28.0	25.0	-0.02	0.049	1000.0	-1000.0	-0.03	-1000.0
Regulation of Androgen receptor activity	1.0	130.0	70.0	-0.132	0.039	1000.0	-1000.0	-0.038	-1000.0
Ras signaling in the CD4+ TCR pathway	1.0	24.0	17.0	-0.013	0.046	1000.0	-1000.0	-0.026	-1000.0
Aurora B signaling	1.0	98.0	67.0	-0.088	0.041	1000.0	-1000.0	-0.042	-1000.0
Regulation of cytoplasmic and nuclear SMAD2/3 signaling	0.0	13.0	23.0	-0.025	0.054	1000.0	-1000.0	-0.023	-1000.0
Canonical NF-kappaB pathway	0.0	20.0	39.0	-0.004	0.052	1000.0	-1000.0	-0.034	-1000.0
Signaling events mediated by HDAC Class II	0.0	18.0	75.0	-0.036	0.076	1000.0	-1000.0	-0.03	-1000.0
Sphingosine 1-phosphate (S1P) pathway	0.0	27.0	28.0	-0.028	0.036	1000.0	-1000.0	-0.022	-1000.0
Circadian rhythm pathway	0.0	6.0	22.0	-0.008	0.048	1000.0	-1000.0	-0.036	-1000.0
a4b1 and a4b7 Integrin signaling	0.0	2.0	5.0	0.014	0.04	1000.0	-1000.0	-0.0	-1000.0
Hedgehog signaling events mediated by Gli proteins	0.0	52.0	65.0	-0.111	0.052	1000.0	-1000.0	-0.047	-1000.0
Aurora A signaling	0.0	41.0	60.0	-0.08	0.065	1000.0	-1000.0	-0.022	-1000.0
Arf6 downstream pathway	0.0	18.0	43.0	-0.04	0.045	1000.0	-1000.0	-0.032	-1000.0
Aurora C signaling	0.0	6.0	7.0	-0.009	0.021	1000.0	-1000.0	-0.009	-1000.0
EPO signaling pathway	0.0	23.0	55.0	-0.005	0.065	1000.0	-1000.0	-0.044	-1000.0
PLK1 signaling events	0.0	79.0	85.0	-0.017	0.047	1000.0	-1000.0	-0.022	-1000.0
Insulin-mediated glucose transport	0.0	26.0	32.0	-0.094	0.047	1000.0	-1000.0	-0.029	-1000.0
PDGFR-alpha signaling pathway	0.0	36.0	44.0	-0.143	0.05	1000.0	-1000.0	-0.04	-1000.0
mTOR signaling pathway	0.0	29.0	53.0	-0.017	0.052	1000.0	-1000.0	-0.04	-1000.0
Class I PI3K signaling events mediated by Akt	0.0	44.0	68.0	-0.094	0.054	1000.0	-1000.0	-0.031	-1000.0
Paxillin-independent events mediated by a4b1 and a4b7	0.0	24.0	37.0	-0.014	0.068	1000.0	-1000.0	-0.039	-1000.0
Signaling events mediated by HDAC Class III	0.0	26.0	40.0	-0.051	0.05	1000.0	-1000.0	-0.02	-1000.0
TRAIL signaling pathway	0.0	40.0	48.0	-0.02	0.061	1000.0	-1000.0	-0.034	-1000.0
Role of Calcineurin-dependent NFAT signaling in lymphocytes	0.0	75.0	83.0	-0.094	0.055	1000.0	-1000.0	-0.033	-1000.0
Signaling events mediated by HDAC Class I	0.0	44.0	104.0	-0.051	0.07	1000.0	-1000.0	-0.035	-1000.0
Paxillin-dependent events mediated by a4b1	0.0	11.0	36.0	-0.057	0.059	1000.0	-1000.0	-0.035	-1000.0
Atypical NF-kappaB pathway	0.0	28.0	31.0	-0.032	0.037	1000.0	-1000.0	-0.024	-1000.0
Syndecan-3-mediated signaling events	0.0	28.0	35.0	-0.074	0.069	1000.0	-1000.0	-0.035	-1000.0
Sumoylation by RanBP2 regulates transcriptional repression	0.0	3.0	27.0	0.0	0.06	1000.0	-1000.0	-0.035	-1000.0
Class I PI3K signaling events	0.0	46.0	73.0	-0.098	0.055	1000.0	-1000.0	-0.033	-1000.0
Arf6 trafficking events	0.0	43.0	71.0	-0.038	0.046	1000.0	-1000.0	-0.027	-1000.0
Insulin Pathway	0.0	53.0	74.0	-0.05	0.064	1000.0	-1000.0	-0.046	-1000.0
Rapid glucocorticoid signaling	0.0	13.0	20.0	-0.02	0.036	1000.0	-1000.0	-0.004	-1000.0
Signaling events mediated by PRL	0.0	23.0	34.0	-0.041	0.04	1000.0	-1000.0	-0.039	-1000.0
Signaling events mediated by Stem cell factor receptor (c-Kit)	0.0	33.0	78.0	-0.02	0.048	1000.0	-1000.0	-0.052	-1000.0
p38 MAPK signaling pathway	0.0	36.0	44.0	-0.081	0.046	1000.0	-1000.0	-0.024	-1000.0
Arf1 pathway	0.0	17.0	54.0	-0.016	0.054	1000.0	-1000.0	-0.018	-1000.0
Alternative NF-kappaB pathway	0.0	4.0	13.0	-0.0	0.067	1000.0	-1000.0	-0.0	-1000.0
Total	194	14553	7203	-12.6428555688	6.76759385847	131000	-131000	-4.99957175313	-131000